- 100 free trades signup offer
- Easy-to-use platform
- Low fees
- Student and young investor discounts
IDEXX Laboratories is a diagnostics & research business based in the US. IDEXX Laboratories shares (IDXX) are listed on the NASDAQ and all prices are listed in US Dollars.
Its last market close was $412.26 – a decrease of 4.59% over the previous week. IDEXX Laboratories employs 11,000 staff and has a trailing 12-month revenue of around $3.8 billion.Our top picks for where to buy IDEXX Laboratories stock
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
- 6% cash rebate plus $2,200 in trading perks
- Low transaction fees
- Easy-to-use app
How to buy IDEXX Laboratories stock
- Choose a stock trading platform. Compare investment platforms.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – IDXX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy IDEXX Laboratories stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
Finder Score for stock trading platforms
To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.
IDEXX Laboratories stock price (NASDAQ: IDXX)
Use our graph to track the performance of IDXX stocks over time.IDEXX Laboratories stocks at a glance
Latest market close | $412.26 |
---|---|
52-week range | $398.50 - $583.39 |
50-day moving average | $438.80 |
200-day moving average | $484.06 |
Wall St. target price | $478.62 |
PE ratio | 39.687 |
Dividend yield | N/A |
Earnings per share (TTM) | $10.35 |
Is it a good time to buy IDEXX Laboratories stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
IDEXX Laboratories price performance over time
Historical closes compared with the close of $409.03 from 2024-12-19
1 week (2024-12-13) | -5.34% |
---|---|
1 month (2024-11-21) | -2.27% |
3 months (2024-09-20) | -19.28% |
6 months (2024-06-21) | -17.49% |
1 year (2023-12-21) | -25.98% |
---|---|
2 years (2022-12-21) | -2.16% |
3 years (2021-12-21) | 624.06 |
5 years (2019-12-20) | 56.39% |
Is IDEXX Laboratories stock undervalued or overvalued?
Valuing IDEXX Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of IDEXX Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
IDEXX Laboratories's P/E ratio
IDEXX Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 40x. In other words, IDEXX Laboratories shares trade at around 40x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stock or simply that they're over-valued.
IDEXX Laboratories's PEG ratio
IDEXX Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.4955. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into IDEXX Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
IDEXX Laboratories's EBITDA
IDEXX Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.3 billion.
The EBITDA is a measure of a IDEXX Laboratories's overall financial performance and is widely used to measure a its profitability.
IDEXX Laboratories financials
Revenue TTM | $3.8 billion |
---|---|
Operating margin TTM | 37.46% |
Gross profit TTM | $2 billion |
Return on assets TTM | 22.79% |
Return on equity TTM | 59.42% |
Profit margin | 22.53% |
Book value | $19.72 |
Market Capitalization | $33.6 billion |
TTM: trailing 12 months
IDEXX Laboratories stock dividends
We're not expecting IDEXX Laboratories to pay a dividend over the next 12 months.
Have IDEXX Laboratories's stocks ever split?
IDEXX Laboratories's stocks were split on a 2:1 basis on 15 June 2015 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your IDEXX Laboratories stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for IDEXX Laboratories stocks, which in turn could have impacted IDEXX Laboratories's stock price.
IDEXX Laboratories stock price volatility
Over the last 12 months, IDEXX Laboratories's stocks have ranged in value from as little as $398.5 up to $583.39. A popular way to gauge a stock's volatility is its "beta."
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while IDEXX Laboratories's is 1.357. This would suggest that IDEXX Laboratories's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
IDEXX Laboratories overview
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups.
Frequently asked questions
What percentage of IDEXX Laboratories is owned by insiders or institutions?Currently 0.942% of IDEXX Laboratories stocks are held by insiders and 94.342% by institutions. How many people work for IDEXX Laboratories?
Latest data suggests 11,000 work at IDEXX Laboratories. When does the fiscal year end for IDEXX Laboratories?
IDEXX Laboratories's fiscal year ends in December. Where is IDEXX Laboratories based?
IDEXX Laboratories's address is: One IDEXX Drive, Westbrook, ME, United States, 04092 What is IDEXX Laboratories's ISIN number?
IDEXX Laboratories's international securities identification number is: US45168D1046 What is IDEXX Laboratories's CUSIP number?
IDEXX Laboratories's Committee on Uniform Securities Identification Procedures number is: 45168D104
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…What are stocks?
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
Read more…More guides on Finder
-
How to buy Northland Power stock in Canada
Steps to owning and managing NPI stock, with 24-hour and historical pricing before you buy.
-
Best renewable energy stocks
These are the best renewable energy stocks to buy now in Canada.
-
Best stocks to buy right now in Canada
Finder’s unique algorithm found the 20 best TSX stocks to buy right now.
-
10 best stock trading platforms and apps in Canada for 2024
Whether you’re a new or experienced investor, these are the best stock trading platforms and apps in Canada.
-
How to buy IL Makiage stock in Canada when it goes public
Everything we know about the IL Makiage IPO plus information on how to buy in.
-
How to buy ByteDance stock in Canada when it goes public
Everything we know about the ByteDance IPO plus information on how to buy in.
-
How to buy Auvik Networks stock in Canada when it goes public
Everything we know about the Auvik Networks IPO plus information on how to buy in.
-
How to buy Universal Music Group (UMG) stock from Canada
If you live in Canada, you need a broker that provides access to foreign investments to buy Universal Music Group stock.
-
How to invest in the S&P 500 in Canada
Find out how to invest in the S&P 500 in Canada—one of the world’s most popular stock indices—to diversify your portfolio.
-
BMO InvestorLine review
Check out the pros and cons of BMO’s self-directed trading platform in our InvestorLine review.